Anaptysbio Inc (NQ: ANAB )
34.18
-0.30
(-0.87%)
Streaming Delayed Price
Updated: 11:48 AM EDT, Jul 17, 2024
Add to My Watchlist
All News about Anaptysbio Inc
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/19/aapharma_15.png?width=1200&height=800&fit=crop)
HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround
September 19, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/09/12/aapharma_15.png?width=1200&height=800&fit=crop)
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
September 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/02/aapharma_4.png?width=1200&height=800&fit=crop)
Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback
September 02, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/28/gsk_1.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio to Participate at the Cowen and Company 43rd Annual Health Care Conference
February 27, 2023
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
12 Health Care Stocks Moving In Friday's Intraday Session
January 06, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/06/image_4.jpg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Thursday's After-Market Session
January 05, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7293.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio to Participate in Upcoming November Investor Conferences
November 09, 2022
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
AnaptysBio Announces Third Quarter 2022 Financial Results and Provides Pipeline Update
November 08, 2022
From AnaptysBio, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/10/05/aapharma_2.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6692.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/04e9e812-bf31-4349-997d-639cc0f17ebf/small/anaptysbio-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/09/13/image19.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.